Paramount Bed Holdings Co., Ltd. (TYO:7817)
2,573.00
-68.00 (-2.57%)
Mar 12, 2025, 3:30 PM JST
Paramount Bed Holdings Revenue
Paramount Bed Holdings had revenue of 26.40B JPY in the quarter ending December 31, 2024, with 13.13% growth. This brings the company's revenue in the last twelve months to 108.03B, up 7.01% year-over-year. In the fiscal year ending March 31, 2024, Paramount Bed Holdings had annual revenue of 106.02B with 7.08% growth.
Revenue (ttm)
108.03B
Revenue Growth
+7.01%
P/S Ratio
1.37
Revenue / Employee
26.18M
Employees
4,126
Market Cap
144.28B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 106.02B | 7.01B | 7.08% |
Mar 31, 2023 | 99.01B | 8.66B | 9.58% |
Mar 31, 2022 | 90.35B | 3.18B | 3.65% |
Mar 31, 2021 | 87.17B | 4.79B | 5.82% |
Mar 31, 2020 | 82.38B | 2.29B | 2.86% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,170.61B |
Takeda Pharmaceutical Company | 4,579.02B |
Daiichi Sankyo Company | 1,795.99B |
HOYA Corporation | 837.44B |
Otsuka Holdings | 2,329.86B |
Terumo | 1,011.15B |
Astellas Pharma | 1,867.63B |
Olympus | 993.33B |